ETF Managers Group, LLC Amgen Inc Transaction History

ETF Managers Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $591,848 - $760,729	-3,128 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $1.41 Million - $1.69 Million	-8,107 Reduced 72.16%	3,128 $610,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $1.09 Million - $1.28 Million	6,535 Added 139.04%	11,235 $2.07 Million
Q1 2019 May 07, 2019	BUY	$180.87 - $203.88 $850,089 - $958,236	4,700 New	4,700 $893,000
Q4 2018 Feb 01, 2019	SELL	$178.4 - $208.25 $2.23 Million - $2.6 Million	-12,487 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $203,263 - $229,152	-1,097 Reduced 8.08%	12,487 $2.59 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $2.26 Million - $2.53 Million	13,584 New	13,584 $2.66 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.